Globus Medical Statistics
Total Valuation
Globus Medical has a market cap or net worth of $7.81 billion. The enterprise value is $7.70 billion.
Market Cap | 7.81B |
Enterprise Value | 7.70B |
Important Dates
The next estimated earnings date is Tuesday, November 4, 2025, after market close.
Earnings Date | Nov 4, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Globus Medical has 135.06 million shares outstanding. The number of shares has increased by 4.89% in one year.
Current Share Class | 112.63M |
Shares Outstanding | 135.06M |
Shares Change (YoY) | +4.89% |
Shares Change (QoQ) | -2.34% |
Owned by Insiders (%) | 17.08% |
Owned by Institutions (%) | 85.70% |
Float | 111.73M |
Valuation Ratios
The trailing PE ratio is 22.48 and the forward PE ratio is 17.33. Globus Medical's PEG ratio is 1.55.
PE Ratio | 22.48 |
Forward PE | 17.33 |
PS Ratio | 3.00 |
Forward PS | 2.56 |
PB Ratio | 1.82 |
P/TBV Ratio | 3.78 |
P/FCF Ratio | 14.81 |
P/OCF Ratio | 11.67 |
PEG Ratio | 1.55 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 10.47, with an EV/FCF ratio of 14.61.
EV / Earnings | 21.60 |
EV / Sales | 2.93 |
EV / EBITDA | 10.47 |
EV / EBIT | 16.61 |
EV / FCF | 14.61 |
Financial Position
The company has a current ratio of 4.07, with a Debt / Equity ratio of 0.03.
Current Ratio | 4.07 |
Quick Ratio | 2.09 |
Debt / Equity | 0.03 |
Debt / EBITDA | 0.16 |
Debt / FCF | 0.23 |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 8.62% and return on invested capital (ROIC) is 6.50%.
Return on Equity (ROE) | 8.62% |
Return on Assets (ROA) | 5.82% |
Return on Invested Capital (ROIC) | 6.50% |
Return on Capital Employed (ROCE) | 10.22% |
Revenue Per Employee | $495,559 |
Profits Per Employee | $67,292 |
Employee Count | 5,300 |
Asset Turnover | 0.53 |
Inventory Turnover | 1.12 |
Taxes
In the past 12 months, Globus Medical has paid $16.89 million in taxes.
Income Tax | 16.89M |
Effective Tax Rate | 4.52% |
Stock Price Statistics
The stock price has decreased by -17.08% in the last 52 weeks. The beta is 1.17, so Globus Medical's price volatility has been higher than the market average.
Beta (5Y) | 1.17 |
52-Week Price Change | -17.08% |
50-Day Moving Average | 57.75 |
200-Day Moving Average | 70.44 |
Relative Strength Index (RSI) | 44.02 |
Average Volume (20 Days) | 962,005 |
Short Selling Information
The latest short interest is 5.76 million, so 4.27% of the outstanding shares have been sold short.
Short Interest | 5.76M |
Short Previous Month | 4.78M |
Short % of Shares Out | 4.27% |
Short % of Float | 5.16% |
Short Ratio (days to cover) | 4.25 |
Income Statement
In the last 12 months, Globus Medical had revenue of $2.63 billion and earned $356.65 million in profits. Earnings per share was $2.57.
Revenue | 2.63B |
Gross Profit | 1.76B |
Operating Income | 463.84M |
Pretax Income | 66.55M |
Net Income | 356.65M |
EBITDA | 735.49M |
EBIT | 463.84M |
Earnings Per Share (EPS) | $2.57 |
Balance Sheet
The company has $229.45 million in cash and $121.41 million in debt, giving a net cash position of $108.04 million or $0.80 per share.
Cash & Cash Equivalents | 229.45M |
Total Debt | 121.41M |
Net Cash | 108.04M |
Net Cash Per Share | $0.80 |
Equity (Book Value) | 4.30B |
Book Value Per Share | 31.81 |
Working Capital | 1.31B |
Cash Flow
In the last 12 months, operating cash flow was $669.16 million and capital expenditures -$141.73 million, giving a free cash flow of $527.43 million.
Operating Cash Flow | 669.16M |
Capital Expenditures | -141.73M |
Free Cash Flow | 527.43M |
FCF Per Share | $3.91 |
Margins
Gross margin is 67.10%, with operating and profit margins of 17.66% and 13.58%.
Gross Margin | 67.10% |
Operating Margin | 17.66% |
Pretax Margin | 14.22% |
Profit Margin | 13.58% |
EBITDA Margin | 28.00% |
EBIT Margin | 17.66% |
FCF Margin | 20.08% |
Dividends & Yields
Globus Medical does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -4.89% |
Shareholder Yield | -4.89% |
Earnings Yield | 4.57% |
FCF Yield | 6.75% |
Analyst Forecast
The average price target for Globus Medical is $87.30, which is 50.93% higher than the current price. The consensus rating is "Buy".
Price Target | $87.30 |
Price Target Difference | 50.93% |
Analyst Consensus | Buy |
Analyst Count | 13 |
Revenue Growth Forecast (5Y) | 9.33% |
EPS Growth Forecast (5Y) | 57.98% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | |
Lynch Upside | |
Graham Number | |
Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Globus Medical has an Altman Z-Score of 10.59 and a Piotroski F-Score of 5.
Altman Z-Score | 10.59 |
Piotroski F-Score | 5 |